LFA
ABBV icon

Livelsberger Financial Advisory’s AbbVie ABBV Stock Holding History

Livelsberger Financial Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,580
Closed -$1.06M – 2
2025
Q3 		$1.06M Buy
4,580
+16
+0.4% +$3.26K 39.51% 1
2025
Q2 		$847K Buy
4,564
+435
+11% +$80.8K 16.4% 1
2025
Q1 		$865K Buy
4,129
+17
+0.4% +$3.31K 41.31% 1
2024
Q4 		$731K Buy
4,112
+19
+0.5% +$3.49K 34.21% 1
2024
Q3 		$808K Buy
4,093
+17
+0.4% +$3.17K 16.94% 1
2024
Q2 		$699K Buy
4,076
+20
+0.5% +$3.31K 10.43% 2
2024
Q1 		$655K Buy
4,056
+17
+0.4% +$2.93K 7.76% 3
2023
Q4 		$626K Buy
+4,039
New +$589K 0.56% 43

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Livelsberger Financial Advisory's ABBV Position: Q4 2025 in Review

Livelsberger Financial Advisory sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 4,580 shares — an estimated $1.06M sold.

Livelsberger Financial Advisory first reported a position in ABBV in Q4 2023 and held it in 8 quarters. The position peaked at $1.06M in Q3 2025. 4,156 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Livelsberger Financial Advisory reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Livelsberger Financial Advisory sold 4,580 AbbVie shares in Q4 2025, an estimated $1.06M.
  • Livelsberger Financial Advisory first reported a position in AbbVie in Q4 2023 and held it in 8 quarters.
  • Livelsberger Financial Advisory's AbbVie position peaked at $1.06M in Q3 2025.
  • 4,156 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Livelsberger Financial Advisory's 13F filing for Q4 2025.